openPR Logo
Press release

Bacterial conjunctivitis market: Driven by increase incidence of conjunctivitis patients across the globe by 2015 - 2021

08-30-2016 01:38 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: zion market research

Bacterial conjunctivitis market: Driven by increase incidence

Conjunctivitis is a communicable disease. It is also known as pink eye in the United States and madras eye in India. Conjunctivitis is an inflammation of conjunctiva. Conjunctivitis caused by bacteria, viruses and allergens. It is highly contagious diseases, spread easily through direct contact of any object like towel, napkin or by coughing and sneezing. Bacterial conjunctivitis caused mainly by both gram positive bacteria and gram negative bacteria. Common bacteria responsible for conjunctivitis are taphylococcus aureus, Pseudomonas, Serratia marcescens, Haemophilus influenza etc.

Request Sample Report: http://www.zionmarketresearch.com/sample/bacterial-conjunctivitis-market

Symptoms of bacterial conjunctivitis are reddening of eyes, excess tears, thick yellow discharge, itching, burning sensation, blurred vision and increase sensitivity towards the light. Treatment includes using antibiotics both systemic and topical. Sometime Povidone-iodine 1.25% ophthalmic solution is also used in African countries like utopia, Uganda as an alternative of antibiotic due to its less cost.

Bacterial conjunctivitis market is driven by increase incidence of conjunctivitis patients across the globe. Exact epidemiology of this disease is difficult to estimate due to its high incidence and low prevalence. Moreover, continuous increasing incidences of bacterial conjunctivitis are responsible for market growth, bacterial conjunctivitis accounts for more than 50% of the cases. Nonetheless, ongoing research and development in the healthcare sector coupled with advancement in medical technologies are expected to open growth avenues for the market over the years.

The report covers forecast and analysis of the bacterial conjunctivitis drug market on a regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Million). To understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the bacterial conjunctivitis drug market has also been included in the study. The report also analyzes several driving and restraining factors and their impact on the market during the forecast period. The study encompasses a market attractiveness analysis, wherein product & regional segments are benchmarked based on their market size, growth rate, and general attractiveness.

Do Inquiry before buying: http://www.zionmarketresearch.com/inquiry/bacterial-conjunctivitis-market

The report provides detailed segmentation of the bacterial conjunctivitis drug market based on product segment and regional segment. Geographically, the market has been segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Demand has been analyzed and forecast based on the current trends for the period of six years. North America was the leading segment of bacterial conjunctivitis drug market followed by Europe in 2015. The bacterial conjunctivitis drug market is expected to witness the good growth in the Asia-Pacific region, especially in India and China in the coming years due to the rising population and pandemic nature of conjunctivitis diseases.

Key players included in the report are Allergan, Inc., Merck, Pfizer, Inc., Novartis and others.

This report segments the global bacterial conjunctivitis markets follows:

Bacterial Conjunctivitis Market: Product Segment Analysis
Fluoroquinolones
Macroloides
Aminoglycosides
Others

Browse detail report at: http://www.zionmarketresearch.com/report/bacterial-conjunctivitis-market

Bacterial Conjunctivitis Market: Regional Segment Analysis
North America
Europe
Asia Pacific
Latin America
The Middle East & Africa

About Us:
Zion Market Research is a single destination for all the industry, company and country reports. We feature large repository of latest industry reports, leading and niche company profiles, and market statistics released by reputed private publishers and public organizations. Zion Market Research is the comprehensive collection of market intelligence products and services available on air. We have market research reports from number of leading industry and update our collection daily to provide our clients with the instant online access to our database. With access to this database, our clients will be able to benefit from expert insights on global industries, products, and market trends.

Contact Us:
Zion Market Research
4283, Express Lane,
Suite 634-143,
Sarasota, Florida 34249, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: http://www.zionmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bacterial conjunctivitis market: Driven by increase incidence of conjunctivitis patients across the globe by 2015 - 2021 here

News-ID: 359518 • Views:

More Releases from zion market research

Halal Food Market to Reach USD 16.84 Billion by 2034, Expanding at 18.04% CAGR
Halal Food Market to Reach USD 16.84 Billion by 2034, Expanding at 18.04% CAGR
The global halal food market, valued at USD 3.21 billion in 2024, is projected to reach USD 16.84 billion by 2034 at a robust CAGR of 18.04%. This extraordinary growth is fueled by a rapidly rising global Muslim population, increasing demand for certified halal-compliant food, expanding global halal trade networks, and the emergence of halal as a trusted, premium, ethical, and hygienic food label even for non-Muslim consumers. Key Market Highlights Metrics Insight 2024
Paper Bags Packaging Market to Reach USD 6.10 Billion by 2034, Expanding at 4.82% CAGR
Paper Bags Packaging Market to Reach USD 6.10 Billion by 2034, Expanding at 4.82 …
The global paper bags packaging market, valued at USD 3.81 billion in 2024, is projected to reach USD 6.10 billion by 2034, growing at a 4.82% CAGR between 2025 and 2034. The market is gaining momentum on the back of sustainability mandates, stringent global regulations against single-use plastic, rising consumer environmental consciousness, and the rapid expansion of e-commerce and foodservice industries adopting recyclable packaging. Key Market Highlights Indicator Insight 2024 Market Value USD 3.81 Billion 2034
Fabry Disease Treatment Market to Reach USD 10.54 Billion by 2034, Expanding at 6.8% CAGR
Fabry Disease Treatment Market to Reach USD 10.54 Billion by 2034, Expanding at …
The global Fabry disease treatment market, valued at USD 5.18 billion in 2024, is projected to reach USD 10.54 billion by 2034, growing at a 6.8% CAGR (2025-2034). Market momentum is driven by rising disease awareness and diagnosis, expanding enzyme replacement therapy (ERT) utilization, progress in chaperone and substrate reduction therapies (SRT), and an advancing pipeline in gene and next-generation ERTs. Persistent unmet need-stemming from organ involvement (renal, cardiac, cerebrovascular),
Snow Sports Apparel Market to Reach USD 5.37 Billion by 2034, Expanding at 7.3% CAGR
Snow Sports Apparel Market to Reach USD 5.37 Billion by 2034, Expanding at 7.3% …
The global snow sports apparel market, valued at USD 2.65 billion in 2024, is projected to reach USD 5.37 billion by 2034, growing at a 7.3% CAGR (2025-2034). Growth is driven by the rising popularity of winter sports and outdoor recreation, fabric and garment-tech innovations (breathability, waterproofing, thermal regulation), and the accelerating role of e-commerce, social media, and athlete-led branding in discovery and conversion. Strategic Market Insights & Key Performance Indicators 2024

All 5 Releases


More Releases for Bacterial

Prominent Bacterial Conjunctivitis Market Trend for 2025: Innovative Eye Drops T …
What Are the Projected Growth and Market Size Trends for the Bacterial Conjunctivitis Market? The bacterial conjunctivitis market has grown steadily, projected to expand from $4.52 billion in 2024 to $4.76 billion in 2025, at a CAGR of 5.3%. Growth factors include rising bacterial infection cases, improved diagnostics, patient education programs, stringent regulatory frameworks, and physician training. The bacterial conjunctivitis market is projected to grow steadily, reaching $5.54 billion by 2029 at
Community-Acquired Bacterial Pneumonia Market
DelveInsight's "Community-Acquired Bacterial Pneumonia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Community-Acquired Bacterial Pneumonia, historical and forecasted epidemiology as well as the Community-Acquired Bacterial Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Community-Acquired Bacterial Pneumonia market report provides current treatment practices, emerging drugs, Community-Acquired Bacterial Pneumonia market share of the individual therapies, and current
Bacterial Conjunctivitis Drugs Market Report 2018: Segmentation by Disease Type …
Global Bacterial Conjunctivitis Drugs market research report provides company profile for Pfizer Inc., Novartis AG, F. Hoffmann-La Roche, Bayer Healthcare, Valeant Pharmaceutical International Inc., Perrigo Company Plc, Akorn Inc., Santen Pharmaceutical Co. Ltd., Allergan Plc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth
Bacterial Conjunctivitis Drugs Market: Rising Incidence of Ophthalmic Bacterial …
The U.S. market for bacterial conjunctivitis drugs has been declining sharply over the last few years. Analysts project the trend to continue in the coming years. In 2013, the market’s opportunity was valued at US$473.3 mn, which is likely to reduce to US$439.8 mn by 2024. In the coming years, the market will have to experience a patent cliff as the top U.S. brands of bacterial conjunctivitis drugs, such as
Bacterial Conjunctivitis Drugs Market Driven by Rising Incidence of Ophthalmic B …
The U.S. market for bacterial conjunctivitis drugs is extremely fragmented, leading to commensurate competition among players. The entry barriers faced by new players despite having good research and development capabilities, is lack of capital, Transparency Market Research (TMR) states in its new report on the U.S. market for bacterial conjunctivitis drugs. R&D involves huge costs and this limits the production. Mergers and acquisitions and other forms of strategic alliances can
02-07-2017 | Health & Medicine
TMR
Bacterial Conjunctivitis Drugs Market Driven by Rising Incidence of Ophthalmic B …
The U.S. market for bacterial conjunctivitis drugs has been declining sharply over the last few years. Analysts project the trend to continue in the coming years. In 2013, the market’s opportunity was valued at US$473.3 mn, which is likely to reduce to US$439.8 mn by 2024. In the coming years, the market will have to experience a patent cliff as the top U.S. brands of bacterial conjunctivitis drugs, such as